Dialectic Therapeutics, Inc. — Form D/A
Dialectic Therapeutics, Inc. of DALLAS, TX, a company, filed a Form D amendment with the SEC on 2021-02-11. The offering totals $6.3M, of which $6.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-02-11
- Form: D/A
- Accession: 0001750926-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.3M
- Amount sold: $6.3M
- Minimum investment: $50K
- Investors: 27
- Date of first sale: 2020-12-15
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-384660
Issuer
- Name: Dialectic Therapeutics, Inc.
- CIK: 0001750926
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 12200 N STEMMONS FREEWAY, DALLAS, TX, 75234
- Phone: 9728888179
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| David Genecov | Director | San Jose, CA |
| John D Harkey | Director | Dallas, TX |
| Robert Hromas | Director | Dallas, TX |
| Daohong Zhou | Director | Dallas, TX |
| David Genecov | Executive Officer | San Jose, CA |
| Joshua D Sills | Executive Officer | Dallas, TX |
| Daohong Zhou | Executive Officer | Dallas, TX |
| Robert Hromas | Executive Officer | Dallas, TX |
Other filings by this issuer (3)
More